Citadel Advisors - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 58 filers reported holding SECOND SIGHT MED PRODS INC in Q1 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q1 2019$19,000
+46.2%
23,546
+63.3%
0.00%
Q4 2018$13,000
-40.9%
14,415
+24.8%
0.00%
Q3 2018$22,000
-47.6%
11,549
-54.2%
0.00%
Q2 2018$42,0000.0%25,239
+18.5%
0.00%
Q4 2016$42,000
-59.2%
21,300
-27.6%
0.00%
Q3 2016$103,000
-42.8%
29,400
-21.1%
0.00%
Q1 2016$180,000
+34.3%
37,270
+278.8%
0.00%
Q2 2015$134,000
+59.5%
9,840
+51.0%
0.00%
Q1 2015$84,0006,5150.00%
Other shareholders

There were no reported owners of SECOND SIGHT MED PRODS INC in Q1 2017.

NameSharesValueWeighting ↓
View complete list of SECOND SIGHT MED PRODS INC shareholders